The musician-turned-biotech-founder waiting to fundraise
Get the full intelligence
Search transcripts, export clips, track mentions, and explore all topics from “The musician-turned-biotech-founder waiting to fundraise” inside PodZeus.
In this episode of Equity, Grammy-nominated musician Aloe Blacc shares his unexpected journey from music stardom to biotech entrepreneurship, revealing how a personal health scare during the pandemic inspired him to fund and build a company focused on cancer research. Blacc co-founded Major Inc. and its subsidiary Pepto-ID to commercialize a groundbreaking molecular discovery platform developed by Dr. Gomika Urugamasoria at the University of Houston. The technology, which uses in silico and in vitro methods to rapidly identify effective molecules binding to diverse biomarkers, promises to cut years and millions from traditional drug development timelines. Despite being a non-scientist founder, Blacc leverages his platform and personal capital to bootstrap the venture while seeking non-dilutive government funding and peer-reviewed validation to attract deeper investment. The episode also explores the dual impact of AI: in biotech, it accelerates discovery, but in music, it threatens artist livelihoods while creating new economic dynamics where record labels may dominate AI-generated content. Blacc reflects on AI as a tool that can enhance creativity but risks shortening the meaningful journey of artistic and scientific creation.
AI can dramatically accelerate biotech drug discovery by combining in silico design with rapid in vitro validation, cutting years and millions from development timelines.
Non-dilutive government funding and peer-reviewed research are critical for early-stage biotech startups to attract deep-pocketed investors.
AI-generated music may benefit record labels more than artists, as they control streaming access and can leverage AI content through existing IP monopolies.
Artists should be compensated for both training data and voice licensing, especially when AI replicates their style or voice.
AI tools like Suno can serve as creative prototypes, but high-fidelity production still requires human collaboration and artistic judgment.
…and 1 more takeaway available in PodZeus
Introducing Aloe Blacc: Musician to Biotech Founder
Rebecca Balan introduces Grammy-winning artist Aloe Blacc as a guest who has transitioned from music to founding a biotech company focused on cancer therapy, setting the stage for a conversation on innovation, funding, and AI.
From Music to Mission: The Pivot to Biotech
Blacc explains how his experience investing in startups led him to build a biotech company after realizing philanthropy alone couldn't sustain high-cost research, especially in oncology.
The Science Behind Pepto-ID: A New Drug Discovery Platform
“He's got 10 patents and each patent has come from this process. Every time he looks for a molecule to bind to a specific biomarker, he's successful.”
Funding the Future: Bootstrapping and Non-Dilutive Support
Blacc discusses the challenges of raising capital in biotech, emphasizing the need for strong scientific validation before approaching investors and relying on government grants and private foundations.
AI in Biotech: Accelerating the FDA Pipeline
The conversation explores how AI is transforming drug discovery, with Blacc highlighting that his co-founder’s platform predates modern AI, making it inherently efficient and reducing the bottleneck between simulation and physical testing.
“The journey is so much more valuable than the destination and AI really does cut that journey time down.”
“He's got 10 patents and each patent has come from this process. Every time he looks for a molecule to bind to a specific biomarker, he's successful.”
“The most popular movie last year was K-pop Demon Hunters... it could have been made by AI because it doesn't sound any different.”
Host
Guest
Aloe Blacc
person
Dr. Gomika Urugamasoria
person
Major Inc.
organization
Pepto-ID
organization
University of Houston
organization
Suno
product
FDA
organization
Spotify
organization
Apple Music
organization
K-pop Demon Hunters
media
Why private wealth is cutting out the VC middleman
Equity • 31m • 4/1/2026
Space: the final frontier of AI infrastructure
Equity • 34m • 4/3/2026
Snowflake’s transition from storing data to shipping with it
Equity • 27m • 4/8/2026
Luma AI's Amit Jain on why most world model companies are getting it completely wrong
Equity • 21m • 4/10/2026
Tokenmaxxing, OpenAI's shopping spree, and the AI Anxiety Gap
Equity • 38m • 4/17/2026
Get the full intelligence
Search transcripts, export clips, track mentions, and explore all topics from “The musician-turned-biotech-founder waiting to fundraise” inside PodZeus.
Start discovering podcast insights today
Start with a 7-day trial and explore a growing catalog of popular podcasts. No credit card required.
No credit card required • 7-day trial • Cancel anytime